These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37574814)

  • 1. A five-pronged critique of 'Serotonin syndrome-A focused review'.
    Gillman PK; Van den Eynde V; Redhead C
    Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):548-549. PubMed ID: 37574814
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting serotonin toxicity in serotonin reuptake inhibitor overdose.
    Cooper J; Duffull SB; Isbister GK
    Clin Toxicol (Phila); 2023 Jan; 61(1):22-28. PubMed ID: 36444913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin syndrome: a case of fatal SSRI/MAOI interaction.
    Keltner N; Harris CP
    Perspect Psychiatr Care; 1994; 30(4):26-31. PubMed ID: 7724340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do serotonin reuptake inhibitors worsen outcome of patients referred to the emergency department for deliberate multi-drug exposure?
    Beaune S; Curis E; Casalino E; Juvin P; Mégarbane B
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):372-7. PubMed ID: 25154631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin Syndrome in an Infant Associated With Linezolid and Opioid Use.
    Essakow J; Jin L; Marupudi N; Wattier R; McQuillen P; Franzon D
    J Pediatr Pharmacol Ther; 2022; 27(6):564-568. PubMed ID: 36988981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
    Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ
    Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin syndrome and drug combinations: focus on MAOI and RIMA.
    Hilton SE; Maradit H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(3):113-9. PubMed ID: 9224903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.
    Gillman PK
    Br J Anaesth; 2005 Oct; 95(4):434-41. PubMed ID: 16051647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.
    Tao R; Rudacille M; Zhang G; Ma Z
    Neuropsychopharmacology; 2014 Jul; 39(8):1996-2007. PubMed ID: 24577320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise.
    Sola CL; Bostwick JM; Hart DA; Lineberry TW
    Mayo Clin Proc; 2006 Mar; 81(3):330-4. PubMed ID: 16529136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
    Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
    Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin Toxicity and Urinary Analgesics: A Case Report and Systematic Literature Review of Methylene Blue-Induced Serotonin Syndrome.
    Zuschlag ZD; Warren MW; K Schultz S
    Psychosomatics; 2018 Nov; 59(6):539-546. PubMed ID: 30104021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin Syndrome in Children and Adolescents Exposed to Selective Serotonin Reuptake Inhibitors - A Review of Literature.
    Xuev S; Ickowicz A
    J Can Acad Child Adolesc Psychiatry; 2021 Aug; 30(3):156-164. PubMed ID: 34381508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serotonin syndrome associated with linezolid use: a case report].
    Sahiner V; Erden Aki SO
    Turk Psikiyatri Derg; 2009; 20(4):398-402. PubMed ID: 20013432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.
    Nelson LS; Erdman AR; Booze LL; Cobaugh DJ; Chyka PA; Woolf AD; Scharman EJ; Wax PM; Manoguerra AS; Christianson G; Caravati EM; Troutman WG
    Clin Toxicol (Phila); 2007 May; 45(4):315-32. PubMed ID: 17486478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitor exposure.
    Fitzgerald KT; Bronstein AC
    Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
    Renoir T
    Front Pharmacol; 2013; 4():45. PubMed ID: 23596418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
    Heiser P; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.